New York, June 13, 2026, 14:04 (EDT)
- Procter & Gamble ended Friday at $149.61, rising 0.86%. The Dow and S&P 500 finished higher as well.
- Bernstein started coverage at Market Perform with a $156 price target. That suggests little room for shares to rise from where they closed on Friday.
- P&G’s next big catalyst is its Q4 fiscal 2026 earnings call, set for July 29.
Procter & Gamble closed out the week at $149.61, gaining 0.86% on the day. Shares ticked up to $149.70 after hours. U.S. stocks ended higher Friday, with the S&P 500 advancing 0.50% and the Dow up 0.70%. Defensive consumer-staples like Procter & Gamble joined the market move.
Bernstein SocGen Group started coverage on P&G, giving the stock a Market Perform rating and setting a $156 price target. That target sits only around 4% above where P&G closed Friday. The move casts the stock’s recent bounce as less of a rerating and more about valuation controls. Bernstein is looking for low single-digit organic sales growth—excluding FX, deals and spinoffs—driven by Beauty, but warns about rising private-label pressure in bathroom tissue and tighter diaper competition from smaller brands.
P&G kept its footing in the latest quarter, beating a lot of consumer peers. The company logged $21.2 billion in net sales in its fiscal third, up 7%. Organic sales rose 3%, and core EPS was up 3% to $1.59. P&G sent out $3.2 billion to shareholders through dividends and buybacks. President and CEO Shailesh Jejurikar called it “solid acceleration in top-line results.” P&G stuck with its existing outlooks for the fiscal year on sales, earnings and cash returns. Procter & Gamble
P&G’s next big test comes with the Q4 fiscal 2026 earnings call, slated for July 29, 2026. The market will be watching to see if organic sales stay up, and if the company can protect margins as it pushes price hikes and productivity gains to counter rising costs. The numbers matter more than usual after P&G flagged in April that after-tax commodity costs and tariffs are expected to weigh by $150 million and $400 million, with fiscal 2026 EPS now tracking at the low end of its target.
P&G is still seen as a resilient play when consumer spending wobbles, the bull case goes. The group has big staples brands like Tide, Pampers, Gillette, Olay, Oral-B and Vicks. It does business in about 70 countries. The company plans about $10 billion for dividends and close to $5 billion for share buybacks in fiscal 2026. P&G pushed its latest quarterly dividend to $1.0885 a share, its 70th straight year hiking the payout.
P&G’s valuation is still the main bearish argument. Shares trade at around 21.9 times earnings, so the P/E is not cheap. The latest analyst initiation puts organic growth in the low single digits. The stock has not moved back to its 52-week high of $167.25. Bernstein’s cautious rating also notes competition and slower growth in the categories, saying those could cap gains even if the core business holds steady.
P&G is fairly valued based on Friday’s price, not especially cheap. The stock still gets backing from dividends, its brands, and buybacks. The issue is the current valuation, which raises the risk if tariffs, commodities, private-label rivals, or softer demand hit earnings. The upcoming earnings on July 29 will be the main focus as investors look for signs that P&G can convert defensive appeal into stronger share performance.
